0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global COVID-19 Vaccine Development Tools Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-18O11712
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global COVID 19 Vaccine Development Tools Market Research Report 2022

Global COVID-19 Vaccine Development Tools Market Research Report 2022

Code: QYRE-Auto-18O11712
Report
August 2022
97 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global COVID-19 Vaccine Development Tools Market

The global COVID-19 Vaccine Development Tools market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Flow Cytometry accounting for % of the COVID-19 Vaccine Development Tools global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While Pharmaceutical Company segment is altered to an % CAGR throughout this forecast period.
China COVID-19 Vaccine Development Tools market size is valued at US$ million in 2021, while the North America and Europe COVID-19 Vaccine Development Tools are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe COVID-19 Vaccine Development Tools landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID-19 Vaccine Development Tools market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID-19 Vaccine Development Tools market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID-19 Vaccine Development Tools market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID-19 Vaccine Development Tools market.
Global COVID-19 Vaccine Development Tools Scope and Market Size
COVID-19 Vaccine Development Tools market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global COVID-19 Vaccine Development Tools market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Flow Cytometry
Electron Microscopy
Spectrometry
Others

Segment by Application

Pharmaceutical Company
Biotechnology Company

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Thermo Fisher Scientific
Pfizer Inc
Celerion
Cole-Parmer Instrument Company
STEMCELL Technologies
Illumina, Inc
AB Sciex Private Limited
Agilent Technologies
Danaher Corporation
Bio-Rad Laboratories
Qiagen NV
Merck KgaA
Shimadzu Corporation
PerkinElmer Inc
Eurofins Scientific
Aurora Biomed
Sartorius AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Flow Cytometry
1.2.3 Electron Microscopy
1.2.4 Spectrometry
1.2.5 Others
1.3 Market by Application
1.3.1 Global COVID-19 Vaccine Development Tools Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Vaccine Development Tools Market Perspective (2017-2028)
2.2 COVID-19 Vaccine Development Tools Growth Trends by Region
2.2.1 COVID-19 Vaccine Development Tools Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 COVID-19 Vaccine Development Tools Historic Market Size by Region (2017-2022)
2.2.3 COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2023-2028)
2.3 COVID-19 Vaccine Development Tools Market Dynamics
2.3.1 COVID-19 Vaccine Development Tools Industry Trends
2.3.2 COVID-19 Vaccine Development Tools Market Drivers
2.3.3 COVID-19 Vaccine Development Tools Market Challenges
2.3.4 COVID-19 Vaccine Development Tools Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue
3.1.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue (2017-2022)
3.1.2 Global COVID-19 Vaccine Development Tools Revenue Market Share by Players (2017-2022)
3.2 Global COVID-19 Vaccine Development Tools Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Vaccine Development Tools Revenue
3.4 Global COVID-19 Vaccine Development Tools Market Concentration Ratio
3.4.1 Global COVID-19 Vaccine Development Tools Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Vaccine Development Tools Revenue in 2021
3.5 COVID-19 Vaccine Development Tools Key Players Head office and Area Served
3.6 Key Players COVID-19 Vaccine Development Tools Product Solution and Service
3.7 Date of Enter into COVID-19 Vaccine Development Tools Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Vaccine Development Tools Breakdown Data by Type
4.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Type (2017-2022)
4.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2023-2028)
5 COVID-19 Vaccine Development Tools Breakdown Data by Application
5.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Application (2017-2022)
5.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America COVID-19 Vaccine Development Tools Market Size (2017-2028)
6.2 North America COVID-19 Vaccine Development Tools Market Size by Country (2017-2022)
6.3 North America COVID-19 Vaccine Development Tools Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe COVID-19 Vaccine Development Tools Market Size (2017-2028)
7.2 Europe COVID-19 Vaccine Development Tools Market Size by Country (2017-2022)
7.3 Europe COVID-19 Vaccine Development Tools Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Vaccine Development Tools Market Size (2017-2028)
8.2 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Country (2017-2022)
8.3 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America COVID-19 Vaccine Development Tools Market Size (2017-2028)
9.2 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2017-2022)
9.3 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Vaccine Development Tools Market Size (2017-2028)
10.2 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2017-2022)
10.3 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific COVID-19 Vaccine Development Tools Introduction
11.1.4 Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Detail
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc COVID-19 Vaccine Development Tools Introduction
11.2.4 Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.2.5 Pfizer Inc Recent Development
11.3 Celerion
11.3.1 Celerion Company Detail
11.3.2 Celerion Business Overview
11.3.3 Celerion COVID-19 Vaccine Development Tools Introduction
11.3.4 Celerion Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.3.5 Celerion Recent Development
11.4 Cole-Parmer Instrument Company
11.4.1 Cole-Parmer Instrument Company Company Detail
11.4.2 Cole-Parmer Instrument Company Business Overview
11.4.3 Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Introduction
11.4.4 Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.4.5 Cole-Parmer Instrument Company Recent Development
11.5 STEMCELL Technologies
11.5.1 STEMCELL Technologies Company Detail
11.5.2 STEMCELL Technologies Business Overview
11.5.3 STEMCELL Technologies COVID-19 Vaccine Development Tools Introduction
11.5.4 STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.5.5 STEMCELL Technologies Recent Development
11.6 Illumina, Inc
11.6.1 Illumina, Inc Company Detail
11.6.2 Illumina, Inc Business Overview
11.6.3 Illumina, Inc COVID-19 Vaccine Development Tools Introduction
11.6.4 Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.6.5 Illumina, Inc Recent Development
11.7 AB Sciex Private Limited
11.7.1 AB Sciex Private Limited Company Detail
11.7.2 AB Sciex Private Limited Business Overview
11.7.3 AB Sciex Private Limited COVID-19 Vaccine Development Tools Introduction
11.7.4 AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.7.5 AB Sciex Private Limited Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies COVID-19 Vaccine Development Tools Introduction
11.8.4 Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.8.5 Agilent Technologies Recent Development
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Detail
11.9.2 Danaher Corporation Business Overview
11.9.3 Danaher Corporation COVID-19 Vaccine Development Tools Introduction
11.9.4 Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.9.5 Danaher Corporation Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories COVID-19 Vaccine Development Tools Introduction
11.10.4 Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Qiagen NV
11.11.1 Qiagen NV Company Detail
11.11.2 Qiagen NV Business Overview
11.11.3 Qiagen NV COVID-19 Vaccine Development Tools Introduction
11.11.4 Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.11.5 Qiagen NV Recent Development
11.12 Merck KgaA
11.12.1 Merck KgaA Company Detail
11.12.2 Merck KgaA Business Overview
11.12.3 Merck KgaA COVID-19 Vaccine Development Tools Introduction
11.12.4 Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.12.5 Merck KgaA Recent Development
11.13 Shimadzu Corporation
11.13.1 Shimadzu Corporation Company Detail
11.13.2 Shimadzu Corporation Business Overview
11.13.3 Shimadzu Corporation COVID-19 Vaccine Development Tools Introduction
11.13.4 Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.13.5 Shimadzu Corporation Recent Development
11.14 PerkinElmer Inc
11.14.1 PerkinElmer Inc Company Detail
11.14.2 PerkinElmer Inc Business Overview
11.14.3 PerkinElmer Inc COVID-19 Vaccine Development Tools Introduction
11.14.4 PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.14.5 PerkinElmer Inc Recent Development
11.15 Eurofins Scientific
11.15.1 Eurofins Scientific Company Detail
11.15.2 Eurofins Scientific Business Overview
11.15.3 Eurofins Scientific COVID-19 Vaccine Development Tools Introduction
11.15.4 Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.15.5 Eurofins Scientific Recent Development
11.16 Aurora Biomed
11.16.1 Aurora Biomed Company Detail
11.16.2 Aurora Biomed Business Overview
11.16.3 Aurora Biomed COVID-19 Vaccine Development Tools Introduction
11.16.4 Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.16.5 Aurora Biomed Recent Development
11.17 Sartorius AG
11.17.1 Sartorius AG Company Detail
11.17.2 Sartorius AG Business Overview
11.17.3 Sartorius AG COVID-19 Vaccine Development Tools Introduction
11.17.4 Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2017-2022)
11.17.5 Sartorius AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Flow Cytometry
    Table 3. Key Players of Electron Microscopy
    Table 4. Key Players of Spectrometry
    Table 5. Key Players of Others
    Table 6. Global COVID-19 Vaccine Development Tools Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global COVID-19 Vaccine Development Tools Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global COVID-19 Vaccine Development Tools Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global COVID-19 Vaccine Development Tools Market Share by Region (2017-2022)
    Table 10. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global COVID-19 Vaccine Development Tools Market Share by Region (2023-2028)
    Table 12. COVID-19 Vaccine Development Tools Market Trends
    Table 13. COVID-19 Vaccine Development Tools Market Drivers
    Table 14. COVID-19 Vaccine Development Tools Market Challenges
    Table 15. COVID-19 Vaccine Development Tools Market Restraints
    Table 16. Global COVID-19 Vaccine Development Tools Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global COVID-19 Vaccine Development Tools Market Share by Players (2017-2022)
    Table 18. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2021)
    Table 19. Ranking of Global Top COVID-19 Vaccine Development Tools Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by COVID-19 Vaccine Development Tools Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players COVID-19 Vaccine Development Tools Product Solution and Service
    Table 23. Date of Enter into COVID-19 Vaccine Development Tools Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global COVID-19 Vaccine Development Tools Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2017-2022)
    Table 27. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2023-2028)
    Table 29. Global COVID-19 Vaccine Development Tools Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2017-2022)
    Table 31. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2023-2028)
    Table 33. North America COVID-19 Vaccine Development Tools Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America COVID-19 Vaccine Development Tools Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe COVID-19 Vaccine Development Tools Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe COVID-19 Vaccine Development Tools Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Thermo Fisher Scientific Company Detail
    Table 44. Thermo Fisher Scientific Business Overview
    Table 45. Thermo Fisher Scientific COVID-19 Vaccine Development Tools Product
    Table 46. Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 47. Thermo Fisher Scientific Recent Development
    Table 48. Pfizer Inc Company Detail
    Table 49. Pfizer Inc Business Overview
    Table 50. Pfizer Inc COVID-19 Vaccine Development Tools Product
    Table 51. Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 52. Pfizer Inc Recent Development
    Table 53. Celerion Company Detail
    Table 54. Celerion Business Overview
    Table 55. Celerion COVID-19 Vaccine Development Tools Product
    Table 56. Celerion Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 57. Celerion Recent Development
    Table 58. Cole-Parmer Instrument Company Company Detail
    Table 59. Cole-Parmer Instrument Company Business Overview
    Table 60. Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Product
    Table 61. Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 62. Cole-Parmer Instrument Company Recent Development
    Table 63. STEMCELL Technologies Company Detail
    Table 64. STEMCELL Technologies Business Overview
    Table 65. STEMCELL Technologies COVID-19 Vaccine Development Tools Product
    Table 66. STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 67. STEMCELL Technologies Recent Development
    Table 68. Illumina, Inc Company Detail
    Table 69. Illumina, Inc Business Overview
    Table 70. Illumina, Inc COVID-19 Vaccine Development Tools Product
    Table 71. Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 72. Illumina, Inc Recent Development
    Table 73. AB Sciex Private Limited Company Detail
    Table 74. AB Sciex Private Limited Business Overview
    Table 75. AB Sciex Private Limited COVID-19 Vaccine Development Tools Product
    Table 76. AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 77. AB Sciex Private Limited Recent Development
    Table 78. Agilent Technologies Company Detail
    Table 79. Agilent Technologies Business Overview
    Table 80. Agilent Technologies COVID-19 Vaccine Development Tools Product
    Table 81. Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 82. Agilent Technologies Recent Development
    Table 83. Danaher Corporation Company Detail
    Table 84. Danaher Corporation Business Overview
    Table 85. Danaher Corporation COVID-19 Vaccine Development Tools Product
    Table 86. Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 87. Danaher Corporation Recent Development
    Table 88. Bio-Rad Laboratories Company Detail
    Table 89. Bio-Rad Laboratories Business Overview
    Table 90. Bio-Rad Laboratories COVID-19 Vaccine Development Tools Product
    Table 91. Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 92. Bio-Rad Laboratories Recent Development
    Table 93. Qiagen NV Company Detail
    Table 94. Qiagen NV Business Overview
    Table 95. Qiagen NV COVID-19 Vaccine Development ToolsProduct
    Table 96. Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 97. Qiagen NV Recent Development
    Table 98. Merck KgaA Company Detail
    Table 99. Merck KgaA Business Overview
    Table 100. Merck KgaA COVID-19 Vaccine Development ToolsProduct
    Table 101. Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 102. Merck KgaA Recent Development
    Table 103. Shimadzu Corporation Company Detail
    Table 104. Shimadzu Corporation Business Overview
    Table 105. Shimadzu Corporation COVID-19 Vaccine Development ToolsProduct
    Table 106. Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 107. Shimadzu Corporation Recent Development
    Table 108. PerkinElmer Inc Company Detail
    Table 109. PerkinElmer Inc Business Overview
    Table 110. PerkinElmer Inc COVID-19 Vaccine Development ToolsProduct
    Table 111. PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 112. PerkinElmer Inc Recent Development
    Table 113. Eurofins Scientific Company Detail
    Table 114. Eurofins Scientific Business Overview
    Table 115. Eurofins Scientific COVID-19 Vaccine Development ToolsProduct
    Table 116. Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 117. Eurofins Scientific Recent Development
    Table 118. Aurora Biomed Company Detail
    Table 119. Aurora Biomed Business Overview
    Table 120. Aurora Biomed COVID-19 Vaccine Development ToolsProduct
    Table 121. Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 122. Aurora Biomed Recent Development
    Table 123. Sartorius AG Company Detail
    Table 124. Sartorius AG Business Overview
    Table 125. Sartorius AG COVID-19 Vaccine Development ToolsProduct
    Table 126. Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2017-2022) & (US$ Million)
    Table 127. Sartorius AG Recent Development
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global COVID-19 Vaccine Development Tools Market Share by Type: 2021 VS 2028
    Figure 2. Flow Cytometry Features
    Figure 3. Electron Microscopy Features
    Figure 4. Spectrometry Features
    Figure 5. Others Features
    Figure 6. Global COVID-19 Vaccine Development Tools Market Share by Application in 2021 & 2028
    Figure 7. Pharmaceutical Company Case Studies
    Figure 8. Biotechnology Company Case Studies
    Figure 9. COVID-19 Vaccine Development Tools Report Years Considered
    Figure 10. Global COVID-19 Vaccine Development Tools Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global COVID-19 Vaccine Development Tools Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global COVID-19 Vaccine Development Tools Market Share by Region: 2021 VS 2028
    Figure 13. Global COVID-19 Vaccine Development Tools Market Share by Players in 2021
    Figure 14. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Vaccine Development Tools Revenue in 2021
    Figure 16. North America COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America COVID-19 Vaccine Development Tools Market Share by Country (2017-2028)
    Figure 18. United States COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe COVID-19 Vaccine Development Tools Market Share by Country (2017-2028)
    Figure 22. Germany COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific COVID-19 Vaccine Development Tools Market Share by Region (2017-2028)
    Figure 30. China COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America COVID-19 Vaccine Development Tools Market Share by Country (2017-2028)
    Figure 38. Mexico COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa COVID-19 Vaccine Development Tools Market Share by Country (2017-2028)
    Figure 42. Turkey COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia COVID-19 Vaccine Development Tools Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Thermo Fisher Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 45. Pfizer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 46. Celerion Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 47. Cole-Parmer Instrument Company Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 48. STEMCELL Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 49. Illumina, Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 50. AB Sciex Private Limited Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 51. Agilent Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 52. Danaher Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 53. Bio-Rad Laboratories Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 54. Qiagen NV Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 55. Merck KgaA Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 56. Shimadzu Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 57. PerkinElmer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 58. Eurofins Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 59. Aurora Biomed Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 60. Sartorius AG Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS